000 01231 a2200313 4500
005 20250516225350.0
264 0 _c20150416
008 201504s 0 0 eng d
022 _a1540-336X
024 7 _a10.1097/PPO.0000000000000063
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGettinger, Scott
245 0 0 _aB7-H1/PD-1 blockade therapy in non-small cell lung cancer: current status and future direction.
_h[electronic resource]
260 _bCancer journal (Sudbury, Mass.)
_c
300 _a281-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aB7-H1 Antigen
_xantagonists & inhibitors
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aLung Neoplasms
_xdiet therapy
650 0 4 _aProgrammed Cell Death 1 Receptor
_xantagonists & inhibitors
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aHerbst, Roy S
773 0 _tCancer journal (Sudbury, Mass.)
_gvol. 20
_gno. 4
_gp. 281-9
856 4 0 _uhttps://doi.org/10.1097/PPO.0000000000000063
_zAvailable from publisher's website
999 _c24075127
_d24075127